An analysis of the biological disease-modifying antirheumatic drug-free condition of adalimumab-treated rheumatoid arthritis patients

Satoshi Ito,Daisuke Kobayashi,Eriko Hasegawa,Chinatsu Takai,Tetsuya Nemoto,Hyunho Lee,Asami Abe,Hiroshi Otani,Hajime Ishikawa,Akira Murasawa,Ichiei Narita,Kiyoshi Nakazono

An analysis of the biological disease-modifying antirheumatic drug-free condition of adalimumab-treated rheumatoid arthritis patients

2019

Satoshi Ito
Daisuke Kobayashi
Eriko Hasegawa
Chinatsu Takai
Tetsuya Nemoto
Hyunho Lee
Asami Abe
Hiroshi Otani
Hajime Ishikawa
Akira Murasawa
Ichiei Narita
Kiyoshi Nakazono

Objectives The present study was performed with the aim of analyzing the biological disease-modifying antirheumatic drug (bDMARD)-free (Bio-free) condition of adalimumab (ADA)-treated rheumatoid arthritis (RA) patients in a real-world setting.

Keywords:

Rheumatoid arthritis
Disease-modifying antirheumatic drug
Diabetes mellitus
Methotrexate
Adalimumab
Internal medicine
Medicine
Cardiology
Discontinuation
Prednisolone
Multivariate analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations